SMC4 overexpression markedly promoted glioma cell migration and invasive capability in vitro, as well as tumorigenicity in vivo, which was involved in alteration of expression of the invasion-related gene MMP2, MMP9 and the proliferation marker Ki67, but SMC4 downregulation reduced it. The gene discussed is MMP9; the disease is central nervous system cancer.